InsidersTradesSigma
Follow the 株式会社ステムリム stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are listed on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社ステムリム has published 5 reports. Market capitalisation: €18.8bn. The latest transaction was filed on 21 July 2026 (Holding update). Among the most active insiders: Tomita Kensuke. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
株式会社ステムリム is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.